WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

about

Natural killer cells inhibit oxaliplatin-resistant colorectal cancer by repressing WBSCR22 via upregulating microRNA-146b-5p.Drug resistance and new therapies in colorectal cancer

P2860

Q55213979-315C1F8B-1DCD-415F-A694-13FA56EA623E Q58740344-3175AC37-ACD2-412C-8078-011E7C18F35F

P2860

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

Item

http://www.wikidata.org/entity/Q46262349

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@en

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@nl

type

Item

label

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@en

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@nl

prefLabel

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@en

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@nl

P1476

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

@en

P2093

Dongmei Yan

http://www.w3.org/2001/XMLSchema#string

Haining Yuan

http://www.w3.org/2001/XMLSchema#string

Jianfei Fang

http://www.w3.org/2001/XMLSchema#string

Linglan Tu

http://www.w3.org/2001/XMLSchema#string

Liyan Cheng

http://www.w3.org/2001/XMLSchema#string

Xiaoju Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoliang Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Identification of additional transcripts in the Williams-Beuren syndrome critical region

Characterization of two novel genes, WBSCR20 and WBSCR22, deleted in Williams-Beuren syndrome

KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells

Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells

Mitochondrial membrane permeabilization in cell death

Cellular processing of platinum anticancer drugs

Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome.

In vitro studies on the mechanisms of oxaliplatin resistance.

Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.

P2888

s41598-017-15749-z

P304

15443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-15749-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29133897

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5684350

http://www.w3.org/2001/XMLSchema#string

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

about

P2860

P2860

WBSCR22 confers oxaliplatin resistance in human colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932